[Federal Register Volume 68, Number 150 (Tuesday, August 5, 2003)]
[Notices]
[Page 46226]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-19814]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated March 14, 2003, and published in the Federal 
Register on April 2, 2003, (68 FR 16089), Mallinckrodt, Inc., 
Mallinckrodt & Second Streets, St. Louis, Missouri 63147, made 
application by renewal to the Drug Enforcement Administration for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............  I
Codeine-N-oxide (9053).....................  I
Dihydromorphine (9145).....................  I
Dihydromorphine (9145).....................  I
Difenoxin (9168)...........................  I
Heroin (9200)..............................  I
Morphine-N-oxide (9307)....................  I
Nicomorphine (9312)........................  I
Normorphine (9313).........................  I
Norlevorphanol (9634)......................  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Methylphenidate (1724).....................  II
Codeine (9050).............................  II
Diprenorphine (9058).......................  II
Etorphine HCL (9059).......................  II
Dihydrocodeine (9120)......................  II
Hydromorphone (9150).......................  II
Oxycodone (9143)...........................  II
Diphenoxylate (9170).......................  II
Benzoylecgonine (9180).....................  II
Hydrocodone (9193).........................  II
Levorphanol (9220).........................  II
Meperidine (9230)..........................  II
Methadone (9250)...........................  II
Methadone Intermediate (9254)..............  II
Metopon (9260).............................  II
Dextropropoxyphene, bulk (9273)............  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
Opium extracts (9610)......................  II
Opium fluid extract (9620).................  II
Opium fluid extract (9620).................  II
Opium tincture (9630)......................  II
Opium, powdered (9639).....................  II
Opium, granulated (9640)...................  II
Levo-alphacetylmethadol (9648).............  II
Oxymorphone (9652).........................  II
Alfentanil (9737)..........................  II
Sufentanil (9740)..........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The above cited Notice of Application contained an error in that 
the drug code for Oxycodone was listed as 9160 rather than 9143.
    The firm plans to manufacture the listed controlled substances for 
internal use and for sale to other companies.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Mallinckrodt, Inc. to manufacture 
the listed controlled substances is consistent with the public interest 
at this time. DEA has investigated Mallinckrodt, Inc. to ensure that 
the company's registration is consistent with the public interest. This 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 
0.104, the Deputy Assistant Administrator, Office of Diversion Control, 
hereby orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed is granted.

    Dated: July 22, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-19814 Filed 8-4-03; 8:45 am]
BILLING CODE 4410-09-M